From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work
Abstract Background Randomised, double-blind, clinical trial methodology minimises bias in the measurement of treatment efficacy. However, most phase III trials in non-orphan diseases do not include individuals from the population to whom efficacy findings will be applied in the real world. Thus, a...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2019-07-01
|
| Series: | Drugs - Real World Outcomes |
| Online Access: | http://link.springer.com/article/10.1007/s40801-019-0159-z |